会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Modeling properties of data and events as transformations of document data and system values
    • 将数据和事件的属性建模为文档数据和系统值的转换
    • US09396446B2
    • 2016-07-19
    • US13284020
    • 2011-10-28
    • Gerd RitterRene GrossTim KornmannSteffen TatzelDirk StumpfDirk Giebel
    • Gerd RitterRene GrossTim KornmannSteffen TatzelDirk StumpfDirk Giebel
    • G06F3/048G06Q10/06G06Q10/10
    • G06Q10/06G06Q10/10
    • A system and method for modeling properties of data and events of a business application is presented. The system include a user interface frontend system that displays a user interface, and a user interface backend system that hosts a business application that generates the user interface for display in the user interface frontend system. The system further includes an enterprise service framework comprising one or more data processors that define one or more properties of data and/or events related to the business application, and model each of the one or more properties as a data field of the business application. A dynamic properties calculator includes one or more data processors that access a set of transformation logic representing data transformation rules for each of the data fields of the business application, and apply the transformation rules to the data fields that represent the one or more properties.
    • 介绍了一种用于建模业务应用程序的数据和事件属性建模的系统和方法。 该系统包括显示用户界面的用户界面前端系统,以及主机业务应用程序的用户界面后端系统,用于生成用户界面以在用户界面前端系统中显示。 所述系统还包括企业服务框架,其包括一个或多个数据处理器,所述数据处理器定义与所述业务应用相关的数据和/或事件的一个或多个属性,以及将所述一个或多个属性中的每个属性建模为所述业务应用的数据字段。 动态属性计算器包括访问代表业务应用的每个数据字段的数据变换规则的一组变换逻辑的一个或多个数据处理器,并将转换规则应用于表示一个或多个属性的数据字段。
    • 8. 发明授权
    • Analogs of alpha galactosyceramide and uses thereof
    • α半乳糖苷酰胺的类似物及其用途
    • US08039670B2
    • 2011-10-18
    • US12083673
    • 2006-10-25
    • Vincenzo CerundoloRichard SchmidtGopal ReddyRengarajan BalamuruganGerd RitterGurdyal BesraMariolina SalioJonathan Silk
    • Vincenzo CerundoloRichard SchmidtGopal ReddyRengarajan BalamuruganGerd RitterGurdyal BesraMariolina SalioJonathan Silk
    • C07C233/18C07C233/20C07C305/20C07F9/09A61K31/66A61K31/661A61K31/16
    • C07H15/00
    • There are disclosed compound of formula I, in which R1 represents a hydrophobic moiety adapted to occupy the C′ channel of human CDId, R2 represents a hydrophobic moiety adapted to occupy the A′ channel of human CDId, such that R1 fills at least at least 30% of the occupied volume of the C′ channel compared to the volume occupied by the terminal nC14H29 of the sphingosine chain of α-galactosylceramide when bound to human CDId and R2 fills at least 30% of the occupied volume of the A′ channel compared to the volume occupied by the terminal nC25H51 of the acyl chain of α-galactosylceramide when bound to human CDId R3 represents hydrogen or OH, Ra and Rb each represent hydrogen and in addition, when R3 represents hydrogen, Ra and Rb together may form a single bond, X represents or —CHA(CHOH)nY or —P(=0)(0−)0CH2(CH0H)mY, in which Y represents CHB1B2, n represents an integer from 1 to 4, m represents 0 or 1, A årepresents hydrogen, one of B1 and B2 represents H, OH or phenyl, and the other represents hydrogen or one of B1 and B2 represents hydroxyl and the other represents phenyl, in addition, when n represents 4, then A together with one of B1 and B2 together forms a single bond and the other of B1 and B2 represents H, OH or OSO3H and pharmaceutically acceptable salts thereof; the compounds of formula I are indicted for use in the treatment of a virus, microbial infection, parasite, an autoimmune disease, cancer, allergy or asthma.
    • 公开了式I的化合物,其中R 1表示适于占据人CD1d的C'通道的疏水性部分,R 2表示适于占据人CDId的A'通道的疏水部分,使得R1至少填充至少 比较C'通道的占据体积的30%,与结合人CD1d和R2的α-半乳糖神经酰胺的鞘氨醇链末端nC14H29占据的体积相比,填充了A'通道占据体积的至少30% 与α-galactosylceramide的酰基链末端nC25H51所占的体积结合到人CDID R3表示氢或OH,Ra和Rb各自表示氢,另外,当R 3表示氢时,R a和R b可以一起形成单 键,X表示或-CHA(CHOH)nY或-P(= O)(0-)0CH 2(CHOH)mY,其中Y表示CHB1B2,n表示1至4的整数,m表示0或1,A 表示氢,B1和B2之一表示H,OH或苯基 另一个代表氢或B1和B2之一表示羟基,另一个表示苯基,另外,当n表示4时,则A与B1和B2中的一个一起形成单键,而B1和B2中的另一个 表示H,OH或OSO 3 H及其药学上可接受的盐; 式I的化合物被指示用于治疗病毒,微生物感染,寄生虫,自身免疫疾病,癌症,变态反应或哮喘。
    • 10. 发明申请
    • Logging And Evaluating Manual Interactions By Users To Support Optimizing And Streamlining Business Processes
    • 记录和评估用户手动交互以支持优化和优化业务流程
    • US20090164932A1
    • 2009-06-25
    • US11960666
    • 2007-12-19
    • Gerd Ritter
    • Gerd Ritter
    • G06F3/048
    • G06F17/243G06Q10/06G06Q10/103G06Q30/0224G06Q30/0244
    • The subject matter disclosed herein provides methods and apparatus, including computer program products, for logging and evaluating activity to support optimizing and streamlining a process, such as a business process. In one aspect, there is provided a computer-implemented method. The method include receiving information representative of activity at a user interface. The received information may be aggregated to form aggregated data. The received information may be evaluated to determine one or more proposals. The evaluation may use the context of a task being performed at the user interface and the activity at the user interface. The one or more proposals may be provided to enable a configuration of a system or a business process with at least one of the proposals. Related apparatus, systems, methods, and articles are also described.
    • 本文公开的主题提供了用于记录和评估活动以支持优化和简化诸如业务过程之类的过程的计算机程序产品的方法和装置。 一方面,提供了一种计算机实现的方法。 该方法包括在用户界面处接收表示活动的信息。 所收到的信息可以被聚合以形成聚合数据。 可以评估所接收的信息以确定一个或多个提案。 评估可以使用在用户界面处执行的任务的上下文以及在用户界面处的活动。 可以提供一个或多个提案以使得能够利用至少一个提案来配置系统或业务流程。 还描述了相关装置,系统,方法和制品。